Autres langues Genocea Biosciences, Inc.

Actions

GNCAQ

US3724274010

Marché Fermé - OTC Markets Autres places de cotation 16:09:18 23/04/2024			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	0,00 %		0,00 %	0,00 %

2023	Genocea Biosciences, Inc. a cessé ses activités	CI
2023	Première déclaration modifiée déposée par Genocea Biosciences, Inc.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Neoantigen-Based Personalized Cancer Therapeutic Vaccines Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023	30/11
Genocea Biosciences, Inc. Went Out of Business	19/05/23
Liquidation Plan Approved for Genocea Biosciences, Inc.	11/05/23
First Amended Disclosure Statement Filed by Genocea Biosciences, Inc.	21/03/23
Disclosure Statement Approved for Genocea Biosciences, Inc.	21/03/23
Joint Liquidation Plan and DIsclosure Statement Filed by Genocea Biosciences, Inc.	09/02/23
Motion for Asset Sale Approved for Genocea Biosciences, Inc.	21/09/22
Motion for Asset Sale Approved for Genocea Biosciences, Inc.	17/08/22
Bidding Procedure Approved for Genocea Biosciences, Inc.	09/08/22
Motion for Asset Sale Filed by Genocea Biosciences, Inc.	04/08/22
Genocea Biosciences, Inc. Filed for Bankruptcy	05/07/22
Genocea Biosciences, Inc.(NasdaqCM:GNCA) dropped from S&P TMI Index	07/06/22
Genocea Biosciences, Inc.(NasdaqCM:GNCA) dropped from NASDAQ Composite Index	02/06/22
GENOCEA BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	01/06/22
Genocea Biosciences, Inc. Announces Resignation of Ali Behbahani from Board of Director	01/06/22
24/7 Market News: Genocea Biosciences, Inc. (NASDAQ: GNCA) Dead Cat bouncing	25/05/22
US Futures Move Lower Ahead of Durable Goods, Investor Confidence Reports	25/05/22
Top Premarket Gainers	25/05/22
Genocea Biosciences To Wind Down Operations; Shares Fall	24/05/22
GENOCEA BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	24/05/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Genocea Biosciences, Inc.

Actions

GNCAQ

US3724274010

Autres langues

Filtres